A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A Single-Arm, blinded, fluorescent PSMA histopathology trial of AS1986NS
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Podejrzenie raka prostaty wymagające wykonania standardowej biopsji wielopunktowej
✗ Disqualifies
- •Pacjenci otrzymujący w tym samym dniu leczenie radioizotopowe (Lutet-177 lub Aktyn-225)
- •Zaburzenia czynności wątroby, nerek lub serca
- •Podwyższona temperatura ciała
- •Słaba funkcja nerek (wskaźnik przesączania poniżej 60 mL/min)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 90 Years
- Last updated (source)
- July 9, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (2)
HCA Florida Kendall Hospital
Miami, United States
Icahn School of Medicine at Mount Sinai (ISMMS)
New York, United States
Trial contact
Amy Wu, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/10/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.